Birchview Capital, LP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$2,528
-99.9%
117,0000.0%1.79%
+12.0%
Q3 2022$2,265,000
+0.9%
117,000
+3.5%
1.60%
-2.3%
Q2 2022$2,244,000
-33.4%
113,0000.0%1.63%
-32.8%
Q1 2022$3,371,000
+28.1%
113,0000.0%2.43%
+43.0%
Q4 2021$2,632,000
-25.4%
113,0000.0%1.70%
-29.3%
Q3 2021$3,526,000
-9.7%
113,000
+1.8%
2.40%
+2.7%
Q2 2021$3,905,000
-0.2%
111,0000.0%2.34%
+0.6%
Q1 2021$3,913,000
+13.4%
111,000
+20.7%
2.32%
+16.9%
Q4 2020$3,451,000
-10.8%
92,000
-20.7%
1.99%
+53.8%
Q3 2020$3,870,000
+204.2%
116,000
+141.7%
1.29%
+68.1%
Q2 2020$1,272,000
+61.8%
48,0000.0%0.77%
+10.3%
Q1 2020$786,000
-35.6%
48,0000.0%0.70%
-21.4%
Q4 2019$1,220,000
+60.5%
48,000
+26.3%
0.89%
+75.3%
Q3 2019$760,000
-38.0%
38,0000.0%0.51%
-32.1%
Q2 2019$1,225,000
+0.1%
38,0000.0%0.74%
-2.9%
Q1 2019$1,224,000
+31.3%
38,0000.0%0.77%
-13.0%
Q4 2018$932,000
-25.6%
38,0000.0%0.88%
+9.2%
Q3 2018$1,252,000
-7.2%
38,0000.0%0.81%
-11.9%
Q2 2018$1,349,000
+72.5%
38,000
+58.3%
0.92%
+78.1%
Q1 2018$782,00024,0000.52%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prosight Management, LP 480,000$14,318,0009.25%
Decheng Capital Management III (Cayman), LLC 518,342$15,462,0004.74%
TANG CAPITAL MANAGEMENT LLC 467,702$13,952,0002.79%
Birchview Capital, LP 113,000$3,371,0002.43%
Privium Fund Management B.V. 351,805$10,494,0002.32%
Sio Capital Management, LLC 144,546$4,312,0001.43%
Perceptive Advisors 2,360,139$70,403,0001.41%
Chicago Capital, LLC 1,011,744$30,180,0001.30%
Endurant Capital Management LP 120,834$3,604,0000.95%
Nicholas Investment Partners, LP 439,235$13,102,0000.93%
View complete list of ALBIREO PHARMA INC shareholders